Ziv-aflibercept in Diabetic Macular Edema: Relation of Subfoveal Choroidal Thickness with Visual and Anatomical Outcomes

Ziv-aflibercept in Diabetic Macular Edema: Relation of Subfoveal Choroidal Thickness with Visual and Anatomical Outcomes

Abstract Purpose: To evaluate the effects of intravitreal ziv-aflibercept injections (IVZ) on subfoveal choroidal thickness (SCT) as well as on central macular thickness (CMT) and on best corrected visual acuity (BCVA) changes in eyes with center-involved diabetic macular edema (CI-DME). Methods: Fi...

Full description

Bibliographic Details
Main Authors:	Siamak Moradian, Masoud Soheilian, Mahsan Asadi, Abdolreza Baghi, Hamid Safi, Seyed-Hossein Abtahi
Format:	Article
Language:	English
Published:	Knowledge E 2023-04-01
Series:	Journal of Ophthalmic & Vision Research
Subjects:	center-involved diabetic macular edema central macular thickness intravitreal subfoveal choroidal thickness ziv-aflibercept
Online Access:	https://doi.org/10.18502/jovr.v18i2.13182

Similar Items

Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
by: Amin E. Nawar, et al.
Published: (2020-10-01)

Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
by: Amin E. Nawar, et al.
Published: (2022-06-01)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
by: Paulose R, et al.
Published: (2016-09-01)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting
by: Munayco-Guillén F, et al.
Published: (2023-04-01)

Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial
by: Sinawat S, et al.
Published: (2023-09-01)

Correlations between subfoveal choroidal thickness, macular thickness, and visual outcome in neovascular age-related macular degeneration using swept source OCT: insights from intravitreal aflibercept treatment
by: Daniel P. Beraldo, et al.
Published: (2023-11-01)

Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion
by: Imoro Z Braimah, et al.
Published: (2019-01-01)

Functional and subfoveal choroidal thickness correlation analysis before and after surgery in patients with macular epiretinal membrane
by: Hong-Bo Zeng, et al.
Published: (2019-04-01)

Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding
by: Julia de Lima Farah, et al.
Published: (2018-10-01)

Efficacy of Aflibercept and Ranibizumab in the treatment of diabetic macular edema
by: Bing Wu, et al.
Published: (2023-08-01)

One-year results of switching to aflibercept for persistent diabetic macular edema resistant to bevacizumab
by: Mahmoud Alaa Abouhussein, et al.
Published: (2021-01-01)

Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
by: Xiu-Xian Wang, et al.
Published: (2021-12-01)

Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
by: Yoo-Ri Chung, et al.
Published: (2023-03-01)

Subfoveal Choroidal Thickness and Treatment Outcomes of Intravitreal Aflibercept for Branch Retinal Vein Occlusion
by: Yoshihito Sakanishi, et al.
Published: (2021-06-01)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
by: Chen YX, et al.
Published: (2020-03-01)

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion
by: Mohab Eldeeb, et al.
Published: (2017-12-01)

Role of peripheral pan-retinal photocoagulation in diabetic macular edema treated with intravitreal ziv-aflibercept
by: Mansour AM, et al.
Published: (2019-04-01)

Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice
by: Campos Polo R, et al.
Published: (2018-01-01)

Analysis of the related factors of subfoveal choroidal thickness in children with low to moderate myopia
by: Hong-Yan Chen, et al.
Published: (2021-10-01)

Effect of intravitreal bevacizumab on subfoveal choroidal thickness in eyes with diabetic macular edema
by: Haitham Y Al-Nashar
Published: (2016-01-01)

Analysis of the effect of inferior oblique overaction on the retinal layers and choroidal thicknesses
by: Serife Sule Cinar, et al.
Published: (2022-06-01)

Subfoveal choroidal thickness in diabetic macular edema
by: Mohamed DM, et al.
Published: (2019-05-01)

Subfoveal choroidal thickness versus foveal thickness in patients with myopia
by: Walid Mohamed El-Zawahry
Published: (2017-01-01)

Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization
by: E Seul Kim, et al.
Published: (2021-09-01)

Personalized Predictive Modeling of Subfoveal Choroidal Thickness Changes for Myopic Adolescents after Overnight Orthokeratology
by: Xiaohang Chen, et al.
Published: (2022-08-01)

Choroidal structural changes determined by the binarization method after intravitreal aflibercept treatment in neovascular age-related macular degeneration
by: Emine Temel, et al.
Published: (2021-08-01)

Unilateral cystoid macular edema and bilateral subfoveal hyperreflectivity following docetaxel chemotherapy: A case report
by: Laura A. Torrado, et al.
Published: (2020-12-01)

SS-OCT-derived morphometric changes in the choroid in patients with age-related macular degeneration
by: D.O. Peretiahina, et al.
Published: (2020-01-01)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
by: Elfandi S, et al.
Published: (2021-04-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
by: Santosh K Mahapatra, et al.
Published: (2024-01-01)

Combination therapy of intravitreal triamcinolone and photodynamic therapy with verteporfin for subfoveal choroidal neovascularization
by: Hussain Nazimul, et al.
Published: (2006-01-01)

Real-World Experience with Brolucizumab Compared to Aflibercept in Treatment-Naïve and Therapy-Refractory Patients with Diabetic Macular Edema
by: Anne Rübsam, et al.
Published: (2024-03-01)

Retinal pigment epithelium rip following single intravitreal ziv-aflibercept injection
by: Sumit Randhir Singh, et al.
Published: (2018-01-01)

Adult Coats Disease Presenting as Subfoveal Nodule
by: Salim Z. Asaad, et al.
Published: (2018-03-01)

Aflibercept compared with dexamethasone in diabetic macular edema
by: Rodolfo Garretón, et al.
Published: (2021-05-01)

Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema
by: Patricia Udaondo Mirete, et al.
Published: (2023-01-01)

Subfoveal choroidal thickness in a general elderly population; Tehran geriatric eye study
by: Alireza Hashemi, et al.
Published: (2024-03-01)

An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data
by: Dominic Muston, et al.
Published: (2018-12-01)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
by: Kendra A. Klein, et al.
Published: (2017-04-01)